Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 38651-38700 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05898529
COVID Infection in Pediatric Surgical Patient
N/ARecruiting
350 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05725616
Effectiveness of the Anatomical Snuff Box Approach for Coronary Angiography
NARecruiting
326 participants
Started: Jul 1, 2023 · Completed: Mar 31, 2024
1 condition1 sponsor1 location
NCT06120426
En Bloc Resection Versus Separation Surgery Combined With Radiotherapy for the Treatment of Spinal Oligometastatic Tumor.
N/ARecruiting
182 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2027
5 conditions10 sponsors1 location
NCT05293600
Rescue Pharmacotherapy for OSA
PHASE1/PHASE2Recruiting
70 participants
Started: Jul 1, 2023 · Completed: Oct 30, 2026
1 condition1 sponsor1 location
NCT05760144
Endometrial Biopsy in Progestin Contraceptive Users
EARLY_PHASE1Recruiting
52 participants
Started: Jul 1, 2023 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT04370366
Imaging of Endolymphatic Hydrops at 7T MRI
N/ARecruiting
16 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2026
1 condition3 sponsors1 location
NCT06151392
Effect of Probiotic and Zinc Supplementations on the Clinical Outcome in Pediatric Patients with Ventriculitis
PHASE4Recruiting
140 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05839652
Treatment of Orthostatic Hypotension in SCI
PHASE4Recruiting
25 participants
Started: Jul 1, 2023 · Completed: Jun 30, 2026
1 condition2 sponsors2 locations
NCT05919472
Effects of Oral Iron Supplementation on Vaccine Response in Iron Deficient Kenyan Women
NARecruiting
180 participants
Started: Jul 1, 2023 · Completed: Sep 30, 2024
1 condition3 sponsors1 location
NCT06261203
Low Dose Aspirin for Prevention of Early Pregnancy Loss
NARecruiting
250 participants
Started: Jul 1, 2023 · Completed: Jul 15, 2025
1 condition1 sponsor1 location
NCT05946616
Spectral Characteristics of Memory Transformation
NARecruiting
30 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05946785
Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes
EARLY_PHASE1Recruiting
28 participants
Started: Jul 1, 2023 · Completed: Jun 1, 2027
2 conditions1 sponsor1 location
NCT05940441
A Prospective Exploratory Clinical Study of Metronomic Capecitabine as Adjuvant Therapy in Locoregionally Advanced Hypopharyngeal Carcinoma
N/ARecruiting
74 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2027
1 condition1 sponsor1 location
NCT05969964
Can Second Resection for pT1 Bladder Cancer be Avoided After Initial En-Bloc Resection With Negative Safety Margins
N/ARecruiting
370 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06378606
Effect of Technology on Cognitive Function in Elderly
NARecruiting
60 participants
Started: Jul 1, 2023 · Completed: Jun 1, 2024
1 condition2 sponsors1 location
NCT06471855
Clinical and Psychological Adjustment of Patients With LLA: a Multidisciplinary Rehabilitative Intervention Project
NARecruiting
70 participants
Started: Jul 1, 2023 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT05310669
Inspiratory Effort Assessed Through Nasal Pressure Measurement in Patients With Idiopathic Pulmonary Fibrosis
N/ARecruiting
100 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2030
1 condition1 sponsor1 location
NCT06172205
Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC
PHASE3Recruiting
192 participants
Started: Jul 1, 2023 · Completed: Jul 31, 2027
2 conditions1 sponsor1 location
NCT05920863
Lenvatinib Combined with Tislelizumab and TACE Applied As Neoadjuvant Regimen for the Patients of CNLC Stage IB and IIA Hepatocellular Carcinoma with High-risk Recurrence Factors
PHASE2Recruiting
35 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2025
6 conditions1 sponsor1 location
NCT05924997
Adebrelimab, Camrelizumab Plus Apatinib as First-line Therapy in Patients With Advanced Hepatocellular Carcinoma
PHASE1/PHASE2Recruiting
52 participants
Started: Jul 1, 2023 · Completed: Jun 1, 2026
1 condition1 sponsor1 location
NCT06551311
The Effects of Eccentric Cycling Exercise Program in Chronic Kidney Disease Patients
NARecruiting
90 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05780164
Improving Access to Lung Cancer Clinical Trials
N/ARecruiting
36 participants
Started: Jul 1, 2023 · Completed: Jun 30, 2025
5 conditions2 sponsors1 location
NCT06187727
Henagliflozin Reducing Infarct Size After Priamry PCI in Patients With ST Segment Elevation Myocardial Infarction
PHASE4Recruiting
240 participants
Started: Jul 1, 2023 · Completed: Oct 1, 2024
2 conditions1 sponsor1 location
NCT06730204
Standardized Nutritional Management of Pediatric Patients With Solid Tumors
NARecruiting
400 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT05616819
Effect of Morning Light Exposure on Mood
NARecruiting
480 participants
Started: Jul 1, 2023 · Completed: Jan 1, 2026
2 conditions2 sponsors1 location
NCT06140992
PaCIFiC-CUP Classifies Cancer of Unknown Primary
N/ARecruiting
120 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2025
2 conditions15 sponsors1 location
NCT05858632
Immune Spatial Features of Guselkumab Cutaneous Response
PHASE4Recruiting
10 participants
Started: Jul 1, 2023 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT05781113
A Novel Wearable Digital Biomarker for Detecting Changes in Multiple Sclerosis (MS) Condition
N/ARecruiting
90 participants
Started: Jul 1, 2023 · Completed: Mar 1, 2026
1 condition5 sponsors3 locations
NCT06503640
Coronary Microvascular Dysfunction in Angina Patients With Non-obstructive Coronary Artery Disease (ANOCA-CMD)
N/ARecruiting
100 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05709912
Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant
NARecruiting
120 participants
Started: Jul 1, 2023 · Completed: Dec 1, 2025
2 conditions2 sponsors1 location
NCT06026969
Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease Exposure
N/ARecruiting
40 participants
Started: Jul 1, 2023 · Completed: Jun 30, 2025
6 conditions3 sponsors1 location
NCT06008860
A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection
PHASE4Recruiting
280 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05922644
Short-term Cervical Spinal Cord Stimulation in Patients With Disorders of Consciousness After Intracerebral Hemorrhage
NARecruiting
344 participants
Started: Jul 1, 2023 · Completed: Sep 1, 2030
2 conditions3 sponsors1 location
NCT05564598
CMV CTLs in Neonates With CMV Infection
PHASE2Recruiting
23 participants
Started: Jul 1, 2023 · Completed: Oct 31, 2028
1 condition1 sponsor4 locations
NCT06015971
Omega-3 Fatty Acids and Nutritional Support in Gastrointestinal Cancer
NARecruiting
40 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05941377
Enhanced Versus Standard Blood Pressure Lowering on Intracranial Aneurysm Rupture or Growth China Antihypertensive Trial for Intracranial Aneurysm (ChATIA-1)
NARecruiting
520 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2026
1 condition5 sponsors1 location
NCT06005363
CSF Metabolomics and Glymphatic Function in Patients Receiving VP- Shunt Surgery.
NARecruiting
48 participants
Started: Jul 1, 2023 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT06313645
Vascular Senescence and Atherosclerotic Plaque Vulnerability
N/ARecruiting
300 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05791617
PET/MR in Post Stroke Cardiac Inflammation Study
N/ARecruiting
12 participants
Started: Jul 1, 2023 · Completed: Sep 2, 2025
2 conditions1 sponsor1 location
NCT05892237
CIETAI and Sequential Radiotherapy in Squamous Lung Cancer
PHASE2Recruiting
50 participants
Started: Jul 1, 2023 · Completed: Jun 1, 2026
1 condition1 sponsor1 location
NCT06209918
Effect of Bioptron Light on Carpal Tunnel Syndrome(BLCTS)
NARecruiting
62 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05623267
Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT
PHASE2/PHASE3Recruiting
346 participants
Started: Jul 1, 2023 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT05945277
Critical Time Intervention-Peer Support
NARecruiting
60 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2025
4 conditions2 sponsors3 locations
NCT05749419
Vaccinations and People With Disabilities
N/ARecruiting
1,000 participants
Started: Jul 1, 2023 · Completed: Jan 31, 2026
5 conditions2 sponsors1 location
NCT06759779
Inspiratory and Expiratory Muscle Training in Adolescent Volleyball Players
NARecruiting
26 participants
Started: Jul 1, 2023 · Completed: Mar 1, 2025
1 condition1 sponsor1 location
NCT05915442
Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer
PHASE2Recruiting
23 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT05906316
A Prospective, Multicenter, Single-arm MAC-PD Cohort: a NTM-NET and ESGMYC Collaborative Study
N/ARecruiting
100 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2026
1 condition1 sponsor11 locations
NCT06758960
Analysis of Biological Progression and Regression of HELLP Syndrome in Time
N/ARecruiting
70 participants
Started: Jul 1, 2023 · Completed: Aug 31, 2025
2 conditions1 sponsor1 location
NCT05742269
Molecular PD-L1 PET/CT Imaging With 89Zr-atezolizumab in Metastatic Triple Negative Breast Cancer
N/ARecruiting
64 participants
Started: Jul 1, 2023 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT05908227
Effects of Flow Magnitude on Cardiorespiratory Stability During Nasal High Flow Therapy in Preterm Infants
NARecruiting
150 participants
Started: Jul 1, 2023 · Completed: Feb 28, 2026
1 condition1 sponsor2 locations